Related Experiment Video
Updated: Dec 28, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Initiating renal replacement therapy through incremental haemodialysis: Protocol for a randomized multicentre
M Fernández Lucas1,2, G Ruíz-Roso3, J L Merino4
1Servicio de Nefrología, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain. milagros.fernandez@salud.madrid.org.
This clinical trial investigates if starting haemodialysis twice weekly better preserves residual kidney function than the standard thrice-weekly regimen. Results aim to optimize renal replacement therapy initiation for improved patient outcomes.
Area of Science:
- Nephrology
- Clinical Trials
- Renal Replacement Therapy
Background:
- Standard renal replacement therapy initiation involves thrice-weekly haemodialysis, which may not account for residual renal function.
- Observational studies suggest that initiating haemodialysis less frequently could benefit residual renal function.
- This trial addresses the need for robust evidence by avoiding selection bias inherent in observational studies.
Purpose of the Study:
- To evaluate if initiating renal replacement therapy with twice-weekly haemodialysis preserves residual renal function more effectively than a thrice-weekly schedule.
- To explore the impact of different haemodialysis initiation frequencies on uremic toxin levels, dialysis dose, anemia control, and quality of life.
Main Methods:
- A prospective, multi-centre, open-label, randomized clinical trial.
- Inclusion criteria: incident haemodialysis patients with urea clearance rate KrU ≥ 2.5 mL/min/1.73 m².
- Exclusion criteria: anuric patients, acute renal failure, or return to haemodialysis after transplant failure.
- Sample size: 44 patients per group, with a minimum follow-up of 1 year.
- Statistical analysis: intention-to-treat principle, Kaplan-Meier method, log-rank tests, and proportional hazard models.
Main Results:
- The study protocol is described, detailing the methodology for comparing twice-weekly versus thrice-weekly haemodialysis initiation.
- The primary outcome is the preservation of residual renal function.
- Secondary outcomes include uremic toxin levels, dialysis adequacy, nutritional status, quality of life, hospital admissions, and mortality.
Conclusions:
- Observational data suggest incremental dialysis initiation may preserve residual renal function and offer similar or better survival rates.
- This is the first randomized clinical trial designed to rigorously assess the benefits of initiating haemodialysis twice weekly versus thrice weekly.
Related Concept Videos
Continuous Renal Replacement Therapy
Acute Kidney Injury V: Interprofessional Care
Hemodialysis I: Introduction
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Hemodialysis III: Nursing Management
Hemodialysis II: Procedure and Complications

